Prognostic significance of early ischemia after acute myocardial infarction in low-risk patients. IRES (Ischemia Residua) Study Group.

[1]  R. Califf,et al.  Evaluation of Combination Thrombolytic Therapy and Timing of Cardiac Catheterization in Acute Myocardial Infarction: Results of Thrombolysis and Angioplasty in Myocardial Infarction–Phase5 Randomized Trial , 1991, Circulation.

[2]  W. Rogers,et al.  Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. , 1991, Circulation.

[3]  M. Stadius,et al.  Coronary artery revascularization. Critical need for, and consequences of, objective angiographic assessment of lesion severity. , 1990, Circulation.

[4]  M. Motro,et al.  Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction. , 1990, The American journal of cardiology.

[5]  R. Califf,et al.  Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group. , 1990, Circulation.

[6]  E. Braunwald,et al.  Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. The Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-Investigators. , 1990, Journal of the American College of Cardiology.

[7]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico..  MEDICAL SCIENCE GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction , 1990, The Lancet.

[8]  A. Moss,et al.  Prognosis and management after a first myocardial infarction. , 1990, The New England journal of medicine.

[9]  David Oakes,et al.  Prognostic significance of nonfatal myocardial reinfarction , 1990 .

[10]  J. O’Meara,et al.  Ability of dipyridamole-thallium-201 imaging one to four days after acute myocardial infarction to predict in-hospital and late recurrent myocardial ischemic events. , 1990, The American journal of cardiology.

[11]  P. Teirstein,et al.  Initial report of the National Registry of Elective Cardiopulmonary Bypass Supported Coronary Angioplasty. , 1990, Journal of the American College of Cardiology.

[12]  M. Gheorghiade,et al.  Cardiac event rate after non-Q-wave acute myocardial infarction and the significance of its anterior location. , 1989, The American journal of cardiology.

[13]  C. White.  Recurrent ischemic events after successful thrombolysis in acute myocardial infarction. The Achilles' heel of thrombolytic therapy. , 1989, Circulation.

[14]  K. Lee,et al.  Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator. , 1989, Circulation.

[15]  E. Gilpin,et al.  A decision scheme for coronary angiography after acute myocardial infarction. , 1989, Circulation.

[16]  L. Tavazzi,et al.  Randomised controlled trial of subcutaneous calcium-heparin in acute myocardial infarction , 1989 .

[17]  A. Moss,et al.  Occurrence, characteristics and prognostic significance of early postacute myocardial infarction angina pectoris. , 1988, The American journal of cardiology.

[18]  A. M. Skene,et al.  TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION Anglo-Scandinavian Study of Early Thrombolysis (ASSET) , 1988, The Lancet.

[19]  H. White,et al.  Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. , 1987, The New England journal of medicine.

[20]  A. Ross,et al.  Reinfarction, recurrent angina, and reocclusion after thrombolytic therapy. , 1987, Circulation.

[21]  R. W. Brower,et al.  Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: initial patency and influence of maintained infusion on reocclusion rate. , 1987, The American journal of cardiology.

[22]  D. Waters,et al.  Early postinfarction ischemia: clinical, angiographic, and prognostic significance. , 1987, Circulation.

[23]  R. W. Brower,et al.  Early post-infarction angina. Incidence and prognostic relevance. , 1986, European heart journal.

[24]  J. Bigger.  Angina pectoris early after myocardial infarction: clinical experience of the multicentre post-infarction program. , 1986, European heart journal.

[25]  M. Gheorghiade,et al.  The prevalence and clinical significance of residual myocardial ischemia 2 weeks after uncomplicated non-Q wave infarction: a prospective natural history study. , 1986, Circulation.

[26]  P. Serruys,et al.  Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. , 1986, Journal of the American College of Cardiology.

[27]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico..  EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.

[28]  I. Palacios,et al.  Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion. , 1986, Circulation.

[29]  K. Karsch,et al.  Effects of intracoronary streptokinase and intracoronary nitroglycerin infusion on coronary angiographic patterns and mortality in patients with acute myocardial infarction. , 1984, The New England journal of medicine.

[30]  A. Ross,et al.  A randomized, angiographically controlled trial of intracoronary streptokinase in acute myocardial infarction. , 1984, The American journal of cardiology.

[31]  B. Bulkley,et al.  Early post-infarction angina. Ischemia at a distance and ischemia in the infarct zone. , 1981, The New England journal of medicine.

[32]  B. Sobel,et al.  Factors presaging early recurrent myocardial infarction ("extension"). , 1981, The American journal of cardiology.

[33]  E. Veys,et al.  HL-A AND INFECTIVE SACROILEITIS , 1974 .

[34]  Barr Jb,et al.  HOME OR AWAY? , 1964, Lancet.